Photochemistry and Photobiology, 2011, 87 1403
7. Tang, H. M., M. R. Hamblin and C. M. Yow (2007) A compar-
ative in vitro photoinactivation study of clinical isolates of mul-
tidrug-resistant pathogens. J. Infect. Chemother. 13, 87–91.
8. Jori, G., C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, D. Dei,
L. Fantetti, G. Chiti and G. Roncucci (2006) Photody-
namic therapy in the treatment of microbial infections: Basic
principles and perspective applications. Lasers Surg. Med. 38,
468–481.
9. Hamblin, M. R., D. A. O’Donnell, N. Murthy, C. H. Contag and
T. Hasan (2002) Rapid control of wound infections by targeted
photodynamic therapy monitored by in vivo bioluminescence
imaging. Photochem. Photobiol. 75, 51–57.
10. Lembo, A. J., R. A. Ganz, S. Sheth, D. Cave, C. Kelly, P. Levin,
P. T. Kazlas, P. C. Baldwin III, W. R. Lindmark, J. R. McGrath
and M. R. Hamblin (2009) Treatment of Helicobacter pylori
infection with intra-gastric violet light phototherapy: A pilot
clinical trial. Lasers Surg. Med. 41, 337–344.
In conclusion, ACS769F4 is a novel nonionic porphyrin
sensitizer which showed evident in vitro ability to inactivate
E. coli and S. aureus. The results showed clear differences in
sensitivity of prokaryotic and mammalian cells, in terms of
concentration of the sensitizer, and in terms of the light dose
required to cause cell death. These results justify their
disclosure and make ACS769F4 a very promising sensitizer
to be considered for clinical use as an antimicrobial agent. This
is even more relevant taking into account the comparison with
TTAP4+ which was shown to localize in the nucleus of the
tested mammalian cells with interactions with DNA, a
situation with awful perspectives for a molecule intended to
be applied in humans.
11. Garcez, A. S., M. S. Ribeiro, G. P. Tegos, S. C. Nunez, A. O.
Jorge and M. R. Hamblin (2007) Antimicrobial photodynamic
therapy combined with conventional endodontic treatment to
eliminate root canal biofilm infection. Lasers Surg. Med. 39, 59–
66.
12. Garcez, A. S., S. C. Nunez, M. R. Hamblin and M. S. Ribeiro
(2008) Antimicrobial effects of photodynamic therapy on
patients with necrotic pulps and periapical lesion. J. Endod. 34,
138–142.
13. Merchat, M., G. Bertolini, P. Giacomini, A. Villanueva and G.
Jori (1996) Meso-substituted cationic porphyrins as efficient
photosensitizers of gram-positive and gram-negative bacteria.
J. Photochem. Photobiol. B 32, 153–157.
Acknowledgements—The authors wish to thank Professor F. Mendes
(Nuclear and Technological Institute, Portugal) for the valuable
advices for the immunocytochemistry assays, Professor M. D. Amaral
(Centre of Human Genetics, National Institute of Health, Portugal)
for the BHK-21 and HEK cell lines, Mr. Benjamin for the photometer
(Konica Minolta AutoMeter IV F) used to measure the light dose of
our irradiation setup at the beginning of the experiments, and finally
Professor L. Clarke (Faculty of Sciences, University of Lisbon,
Portugal) for revising the manuscript. This work was supported by
‘‘Cancer Light Assisted Receeding Oncologic’’ (CLARO) project grant
˜
(Ageˆ ncia de Inovac¸ ao, Portugal). Both SM and FC were recipients of
research fellowships from CLARO’s grant (Portugal).
14. Caminos, D. A. and E. N. Durantini (2006) Photodynamic inac-
tivation of Escherichia coli immobilized on agar surfaces by a
tricationic porphyrin. Bioorg. Med. Chem. 14, 4253–4259.
15. Caminos, D. A., M. B. Spesia, P. Pons and E. N. Durantini (2008)
Mechanisms of Escherichia coli photodynamic inactivation by an
amphiphilic tricationic porphyrin and 5,10,15,20-tetra(4-N,N,N-
trimethylammoniumphenyl) porphyrin. Photochem. Photobiol.
Sci. 7, 1071–1078.
16. Hamblin, M. R., D. A. O’Donnell, N. Murthy, K. Rajagopalan,
N. Michaud, M. E. Sherwood and T. Hasan (2002) Polycationic
photosensitizer conjugates: Effects of chain length and Gram
classification on the photodynamic inactivation of bacteria.
J. Antimicrob. Chemother. 49, 941–951.
17. Alves, E., L. Costa, C. M. Carvalho, J. P. Tome, M. A. Faustino,
M. G. Neves, A. C. Tome, J. A. Cavaleiro, A. Cunha and A.
Almeida (2009) Charge effect on the photoinactivation of Gram-
negative and Gram-positive bacteria by cationic meso-substituted
porphyrins. BMC Microbiol. 9, 70.
18. Caminos, D. A., M. B. Spesia and E. N. Durantini (2006)
Photodynamic inactivation of Escherichia coli by novel
meso-substituted porphyrins by 4-(3-N,N,N-trimethylammonium-
propoxy)phenyl and 4-(trifluoromethyl)phenyl groups. Photo-
chem. Photobiol. Sci. 5, 56–65.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article:
Figure S1. NMR spectrum of ACS 769F4 (*TFA sinal).
Figure S2. IR spectrum of ACS 769F4: NH band at
3429 cm)1
; ; sulfonamide at
CH saturated at 2929 cm)1
1159 cm)1; porphyrin macocycle at 1557, 1428 and 803 cm)1
Figure S3. ESI spectrum of ACS 769F4.
.
Figure S4. Visible spectrum of ACS 769F4 (CH2Cl2 ⁄
MeOH).
Please note: Wiley-Blackwell is not responsible for the
content or functionality of any supporting information
supplied by the authors. Any queries (other than missing
material) should be directed to the corresponding author for
the article.
19. Lang, K., J. Mosinger and D. M. Wagnerova (2004) Photophys-
´
REFERENCES
ical properties of porphyrinoid sensitizers non-covalently bound
to host molecules; models for photodynamic therapy. Coord.
Chem. Rev. 248, 321–350.
1. Plaetzer, K., B. Krammer, J. Berlanda, F. Berr and T. Kiesslich
(2009) Photophysics and photochemistry of photodynamic ther-
apy: Fundamental aspects. Lasers Med. Sci. 24, 259–268.
2. Tao, J. N., S. M. Duan and J. Li (2007) Experimental studies on
treatment of HSV infections with photodynamic therapy using
5-aminolevulinic acid. Zhonghua Shi Yan He Lin Chuang Bing Du
Xue Za Zhi 21, 79–82.
3. Hamblin, M. R. and T. Hasan (2004) Photodynamic therapy: A
new antimicrobial approach to infectious disease? Photochem.
Photobiol. Sci. 3, 436–450.
4. Fuchs, B. B., G. P. Tegos, M. R. Hamblin and E. Mylonakis
(2007) Susceptibility of Cryptococcus neoformans to photodynamic
inactivation is associated with cell wall integrity. Antimicrob.
Agents Chemother. 51, 2929–2936.
5. Wagner, S. J., A. Skripchenko, J. Salata and L. J. Cardo (2007)
Photoinactivation of Trypanosoma cruzi in red cell suspensions
with thiopyrylium. Transfus. Apher. Sci. 37, 23–25.
20. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D.
Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic
therapy. J. Natl Cancer Inst. 90, 889–905.
21. Ribeiro, S. M., A. C. Serra and A. M. d. Rocha-Golsaves (2007)
Covalently immobilized porphyrins as photooxidation catalysts.
Tetrahedron 63, 7885–7891.
22. Barnett, G. H., M. F. Hudson and K. M. Smith (1975) Con-
cerning meso-tetraphenylporphyrin purification. J. Chem. Soc. 14,
1401–1403.
23. Azenha, E. G., A. C. Serra, M. Pineiro, M. M. Pereira, J. Seixas de
Melo, L. G. Arnaut, S. J. Formosinho and A. M. d’ A. Gonsalves
(2002) Heavy-atom effects on metalloporphyrins and polyhalo-
genated porphyrins. Chem. Phys. 280, 177–190.
24. Bezdetnaya, L., N. Zeghari, I. Belitchenko, M. Barberi-Heyob,
J. L. Merlin, A. Potapenko and F. Guillemin (1996) Spectroscopic
and biological testing of photobleaching of porphyrins in solu-
tions. Photochem. Photobiol. 64, 382–386.
6. Maisch, T. (2007) Anti-microbial photodynamic therapy: Useful
in the future? Lasers Med. Sci. 22, 83–91.